Drug Delivery

The Top 100 Drug Delivery Companies Worldwide

Publication Date	January 2004
Publisher	Research Facts
Product Type	Report
Pages	127
ISBN Number	not applicable
Product Code	RSF00002

Price

£570.00
approximately: $863 | €636

pdf

Order above formats by FAX

Drug delivery technologies can clearly differentiate a drug in today's increasingly complex, crowded and competitive markets. For example, the leading cardiovascular medicine in the United States during the mid-1990's built its success largely on an innovative delivery system. Drug delivery technologies can revive promising compounds which have been abandoned due to formulation problems. Innovative drug delivery technologies can be used to add something new to a compound to get marketing advantage and increase a product's branded lifecycle.

Drug delivery technologies can help minimize adverse side effects, improve the action of a drug through faster onset, time-controlled or site-specific delivery, or reduce the number of doses a patient needs to take. Drug delivery technologies can also help address the pervasive problem of noncompliance.

The future of drug delivery looks very exciting. It is now possible to delivery a macromolecule such as insulin, through pulmonary delivery. Furthermore, drug delivery research could some day produce insulin pills for diabetics or an under-skin pharmacy on a microchip.

This report published in January 2004, profiles the Top 100 companies in the drug delivery market.

Profile information for each company typically includes:

Full Company Contact Information (telephone and fax numbers, emails, websites, addresses and headquarters/parent company)
Key Company Decision Makers - from CEO and Main Board, to Key Senior Managers
Specialised fields such as Product Listings, Turnover, Employment and Year Established
SIC and NAICS Classifications

Report Target Market:

1) Pharmaceutical And Biotechnology Companies

This report is an invaluable tool for pharmaceutical and biotechnology companies looking to ensure that they identify the leading and most-up-to-date drug delivery technologies and collaborate with the most suitable companies.

2) Drug Delivery Companies And Drug Delivery Analysts

This report is also ideal for competitive/financial analysis and partner/alliance identification.

3) Suppliers

In addition, this report is very useful for suppliers of goods and services to the drug delivery industry looking to identify valuable new prospects.

Note: Most companies will be fully aware of the major players in the drug delivery sector but this report looks at all 100 of the top companies in the sector.

Report data field structure is as follows:

Company Name
Company Address
Company Phone
Company Fax
Company Email
Company Web Address
Parent Company
Parent Company Phone
Employment (Individual site/all sites)
Top Executive(s)
Product(s)
SIC Code(s)
NAICS Code(s)
Location Status
Turnover €m
Year Established
Ownership

Research Facts reports help you make informed decisions about the markets and firms that affect your business.

Learn more about your target markets, and target companies
Access top level research on all 100 major players in your market
See which companies dominate your major markets
Get detailed information on particular companies

Formats:

Hardcopy: Bound report, A4 format
Electronic: pdf Version, A4 format
Site License Version: Allows you to post this report on your Intranet/Knowledge Management System, to allow all employees at your organization to access the report electronically.
Mailing List Version: The Mailing List Version allows you to download a CSV table of all 100 companies into your internal databases and/or spreadsheets.

The Top 100 Drug Delivery Companies Worldwide is the third in a highly successful series of reports by Research Facts that already includes The Top 100 In-Vitro Diagnostics Manufacturing Companies In Europe and The Top 100 Point-Of-Care Manufacturing Companies Worldwide.

Please note that due to the nature of this report, no Table of Content is available. Feel free to refer to the sample below for further information.

Company: Alkermes, Inc.
Street Address: 88 Sidney Street, Cambridge, Massachusetts, 02139, United States
Telephone: 001-617-494-0171
Fax: 001-617-494-9263
Email: prodtech@alkermes.com
Website: www.alkermes.com
Employment (Individual Site): 190
Employment (All Sites): 436

Top Executive(s):

Richard F. Pops, Chief Executive Officer
David A. Broecker, President And Chief Operating Officer
James M. Frates, Vice President, Chief Financial Officer And Treasurer
Elliot W. Ehrich, M.D., Vice President Science And Development And Chief Medical Officer
Richard P. Batycky, Ph.D. Vice President,
Pulmonary Research & Development
Stephen E. Zale, Ph.D., Vice President, Injectable Research & Development
Trevor Mundel, M.D., Ph.D., Vice President,
Clinical Development
M. Gary Riley, D.V.M., Ph.D., Vice President,
Toxicology And Applied Biology
Gordon G. Pugh, Vice President, Operations
Paul F. Herbert, Vice President, Process Development
Joseph J. Anisko, Ph.D. Vice President, Quality
Michael S. Giorgetti, Vice President, Quality Assurance
Don G. Burstyn, Ph.D., Vice President, Regulatory Affairs
Kathryn L. Biberstein, Vice President And General Counsel
Claire M. Vasios, Ph.D., Vice President, Intellectual Property
Michael J. Landine, Vice President, Corporate Development
Susanne McGown, Vice President, Business Development

Product(s):

Controlled, Sustained-Release Injectable Drugs Using ProLease And Medisorb Technologies {Microsphere-Based Delivery Systems Composed Of The Desired Bioactive Molecule Incorporated Into A Matrix Of Poly-DL-Lactide-Co-Glycolide (PLG)}, And Inhaled Formulations Based On Proprietary AIR Pulmonary Technology (Proprietary Drug Delivery Technology Composed Of Dry Powders Ideally Suited For Delivery To The Lungs).

SIC Code(s): 2834
NAICS Code(s): 325412